pLOG

2024-04-01

In 2024, Media-WIND Health Strategies / Medicloud Biotech completed ISO 9001/27001/27701 verification.

Media-WIND Health Strategies  Co., Ltd. and  Medicloud Biotech Co., Ltd., subsidiaries of the PATIENTSFORCE Group, not only provide high-quality compliance services but also obtained ISO 9001:2015 Quality Management System certification for the management of patient support programs by the end of 2023, with zero defects successfully verified.

Moreover, in March 2024, they passed the third-party audit verification for the ISO 27001:2022 revised edition. Recommended by SGS as organizations compliant with the requirements of the ISO 27001 Information Security Management System and ISO 27701 Personal Information Protection System.

Compared to the previous ISO 27001:2013 version, the new ISO 27001:2022 edition imposes stricter requirements on existing control measures such as threat intelligence and configuration management, secure software design, data deletion masking, and leak prevention, in addition to strengthening cloud and outsourcing management. According to ISO's regulations regarding the new revision, organizations have three years to complete the relevant requirements of the revision. Leading the industry, Media-WIND Health Strategies Consulting Co., Ltd. and  Medicloud Biotech Technology Co., Ltd. not only successfully renewed their certification but also obtained the new version verification with zero defects. Building upon the stable foundation of personal data protection and information security systems mentioned above,Media-WIND Health Strategies Co., Ltd. and  Medicloud Biotech  Co., Ltd. will continue to uphold the same commitment and beliefs, providing all pharmaceutical clients with high-standard execution of entrusted patient support/assistant program services.
 

Patientforce, Head of Group Compliance Center, Vettius Yang